Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Five years after 9/11 and the anthrax attacks that followed, stakeholders in public health, medicine, and private industry are forging a partnership that anticipates the next generation of deadly challenges to the nation's biodefense.

Dark vision: Medical countermeasures against the next wave of bioterror